Sumitomo Chemical Q1: consol PAT +20% to ₹215 Cr on margins; revenue flat, one-off aids

Sumitomo Chemical India's Q1 FY27 (June quarter) was a margin-led print on a flat topline. Consolidated revenue was essentially unchanged year-on-year at ₹1,063 Cr (+0.6% vs ₹1,057 Cr in Q1 FY26), while consolidated PAT rose ~20% to ₹214.5 Cr from ₹178.1 Cr. But the headline flatters the underlying trend: the quarter includes a ₹26.90 Cr positive exceptional — a business-interruption insurance claim tied to the 2022-23 Bhavnagar plant fire — that the year-ago quarter did not have. Stripping it out (net of tax), adjusted PAT was roughly ₹195 Cr, or about +9% YoY. So the real story is steady, single-digit profit growth on flat sales, driven by cost control and mix rather than volume: standalone tells the same story (revenue +0.6% to ₹1,054 Cr, PAT +20% to ₹216.5 Cr), so consolidated and standalone do not diverge.

Margins did the work. Consolidated net margin expanded to ~20.2% (reported) from ~16.9% a year ago, and stays above year-ago even on the adjusted ~18.3%; operating margin firmed to ~21.9% from ~20.7%. The lift came from softer input costs — cost of materials consumed was broadly flat despite a stronger sales mix, and other expenses actually fell YoY (₹110 Cr vs ₹112 Cr) — consistent with management's stated FY27 plan on the Q4 concall to hold sales levels and pass on cost increases product-by-product to defend margins. On that yardstick the quarter is on-plan: revenue held, margins sustained/expanded. Analyst commentary framing FY27 as 15-20% PAT growth is met on the reported number but sits at the top of the range once the one-off is removed — no broker put out a specific June-quarter consensus, so this is best read as in-line delivery rather than a beat.

The stock went into the print at ₹528.85, up 21.5% over the past month of trading.

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters.

The steep sequential jump (revenue +55%, PAT +93% vs Q4 FY26) is seasonality, not momentum — this is a monsoon-dependent agro-chemicals business whose June (kharif sowing) quarter is structurally its strongest and March its weakest, so QoQ should not be read as acceleration. Two subsidiaries (Barrix Agro Sciences; Excel Crop Care Africa, under liquidation) ran a small net loss (₹1.9 Cr) and remain immaterial. The board also declared the quarter alongside the 26th AGM (July 27) and a ₹1.30 dividend (ex-date July 17). The glyphosate Pest-Control-Operator notification overhang persists but remains stayed by the Delhi High Court pending disposal.